Kiwi biotech Aroa Biosurgery gets 'shot in the arm' from investment in US partner
Tela Bio has up to $US25 million to scale sales and clinical trials of Kiwi-developed regenerative tissue technology.
Fiona Rotherham Wed, 01 Nov 2017
Biomedical company Aroa Biosurgery is boosting its manufacturing capacity and staff numbers after one of its US partners gained investment of up to $US25 million for commercial expansion.
Aroa’s proprietary Endoform technology is a regenerative biomaterial used for replacing tissue within
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
